HAFSAH IQBAL: Open Payments
NPI 1639933575 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 71 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $1,260 · 2025 $1,701
Food & beverage: $1,677Education: $24
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $219 |
| Lilly USA, LLC | 9 | $219 |
| Sequel Med Tech, LLC | 3 | $171 |
| Xeris Pharmaceuticals, Inc. | 5 | $115 |
| Insulet Corporation | 3 | $74 |
| SANOFI-AVENTIS U.S. LLC | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| Amgen Inc. | 3 | $65 |
| Madrigal Pharmaceuticals | 2 | $64 |
| BETA BIONICS, INC. | 2 | $58 |
Products named: TWIIST, MOUNJARO, JARDIANCE, Ozempic, RECORLEV, Omnipod, TZIELD, REZDIFFRA.
Industry payments across VA — which companies pay providers there.
